When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
QLGN - Qualigen Therapeutics jumps 7% after filing IND application for QN-165 in COVID-19
Qualigen Therapeutics Inc.
Qualigen Therapeutics (QLGN) pops 7.3% premarket after submitting an Investigational New Drug ((IND)) application to the FDA for Phase 1b/2a clinical trials of QN-165 with an initial target indication of the treatment of hospitalized COVID-19 patients.QN-165, a DNA aptamer, is a broad-based antiviral drug candidate that has exhibited antiviral activity in multiple in vitro assays against different viruses.